Status:
COMPLETED
PTSD and Self-regulation: Coping, Emotional Regulation and Cognitive Control and Their Relationships to Symptom Management
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Stress Disorders, Post-Traumatic
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Non-pathological stress has an adaptive value, allowing a person to prepare for the demands of everyday life and increasing chances of survival in the face of danger. To "cope", the individual respond...
Detailed Description
Numerous epidemiological studies confirm that psychological trauma is a ubiquitous phenomenon and many researchers consider exposure to trauma to be the norm rather than the exception. However, not al...
Eligibility Criteria
Inclusion
- Definite diagnosis of PTSD
- Aged between 18 and 65
- Stable medication for at least 2 weeks
- Understand, speak and read French fluently
- Having signed the informed consent form
- Being affiliated to the social security system
Exclusion
- Medical condition that would interfere with the ability to give consent and participate in the study
- Presence of a mental condition with suicidal risk that requires priority treatment or care
- Severe psychiatric comorbidity: schizophrenia; bipolar disorder; severe depression
- Neurological disorders
- Intellectual disability
- Pervasive developmental disorder
Key Trial Info
Start Date :
September 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 16 2024
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05400200
Start Date
September 22 2022
End Date
December 16 2024
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, France, 06000